- Home
- PROK vs CLCO Comparison
PROK vs CLCO Comparison
Compare PROK & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- CLCO
- Stock Information
- Founded
- PROK 2015
- CLCO 2018
- Country
- PROK United States
- CLCO United Kingdom
- Employees
- PROK N/A
- CLCO N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- CLCO
- Sector
- PROK Health Care
- CLCO
- Exchange
- PROK Nasdaq
- CLCO Nasdaq
- Market Cap
- PROK 334.8M
- CLCO 360.2M
- IPO Year
- PROK N/A
- CLCO N/A
- Fundamental
- Price
- PROK $2.45
- CLCO $7.85
- Analyst Decision
- PROK Buy
- CLCO
- Analyst Count
- PROK 5
- CLCO 0
- Target Price
- PROK $6.25
- CLCO N/A
- AVG Volume (30 Days)
- PROK 2.4M
- CLCO 68.8K
- Earning Date
- PROK 11-11-2025
- CLCO 08-28-2025
- Dividend Yield
- PROK N/A
- CLCO 7.71%
- EPS Growth
- PROK N/A
- CLCO N/A
- EPS
- PROK N/A
- CLCO 1.04
- Revenue
- PROK $527,000.00
- CLCO $322,034,000.00
- Revenue This Year
- PROK $265.05
- CLCO $1.89
- Revenue Next Year
- PROK N/A
- CLCO N/A
- P/E Ratio
- PROK N/A
- CLCO $7.54
- Revenue Growth
- PROK N/A
- CLCO N/A
- 52 Week Low
- PROK $0.46
- CLCO $4.51
- 52 Week High
- PROK $7.13
- CLCO $11.71
- Technical
- Relative Strength Index (RSI)
- PROK 50.33
- CLCO 55.61
- Support Level
- PROK $2.12
- CLCO $7.50
- Resistance Level
- PROK $3.05
- CLCO $8.10
- Average True Range (ATR)
- PROK 0.23
- CLCO 0.23
- MACD
- PROK 0.03
- CLCO -0.02
- Stochastic Oscillator
- PROK 35.48
- CLCO 52.11
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.